CDK4 and neoplasm: Genomic and transcriptomic studies revealed that amplification of cyclin D1 and CDK4 genes are associated with resistance to immunotherapy and that tumors with hyperexpression of genes promoting cell cycle display a “cold” immune tumor contexture.